1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary: Global Pressure Ulcers Treatment Market4. Market Overview
4.1. Introduction
4.1.1. Treatment Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pressure Ulcers Treatment Market Analysis and Forecast, 2017-2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Pricing Analysis
5.2. Key Mergers & Acquisitions
5.3. Healthcare Industry Overview
5.4. Disease Prevalence & Incidence Rate globally with key countries
5.5. Pipeline Analysis
6. Global Pressure Ulcers Treatment Market Analysis and Forecast, by Treatment
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment, 2017-2027
6.3.1. Wound Care Dressing
6.3.1.1. Antimicrobial Dressings
6.3.1.2. Foam Dressings
6.3.1.3. Hydrocolloid Dressings
6.3.1.4. Film Dressings
6.3.1.5. Alginate Dressings
6.3.1.6. Hydrogel Dressings
6.3.1.7. Other Dressings
6.3.2. Wound Care Devices
6.3.2.1. Negative Pressure Wound Therapy (NPWT)
6.3.2.2. Ultrasound Therapy
6.3.2.3. Others (HBOT & electromagnetic)
6.3.3. Active Therapies
6.3.3.1. Skin Grafts & Substitutes
6.3.3.2. Growth Factors
6.3.3.3. Others (hemostatic agents, sealants (collagen and fibrin sealants))
6.3.4. Others
6.3.4.1. Pressure Relief Devices
6.3.4.2. Traditional Wound Care Products
6.3.4.3. Others
6.4. Market Attractiveness, by Treatment
7. Global Pressure Ulcers Treatment Market Analysis and Forecast, by Wound
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Type of Wound, 2017-2027
7.3.1. Stage 1
7.3.2. Stage 2
7.3.3. Stage 3
7.3.4. Stage 4
7.4. Market Attractiveness, by Wound
8. Global Pressure Ulcers Treatment Market Analysis and Forecast, by End User
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End User, 2017-2027
8.3.1. Hospital Inpatient Settings
8.3.2. Hospital Outpatient Settings
8.3.3. Community Health Centers
8.3.4. Home Healthcare
8.4. Market Attractiveness, by End User
9. Global Pressure Ulcers Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.3. Market Attractiveness, by Country/Region
10. North America Pressure Ulcers Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment, 2017-2027
10.2.1. Wound Care Dressing
10.2.1.1. Antimicrobial Dressings
10.2.1.2. Foam Dressings
10.2.1.3. Hydrocolloid Dressings
10.2.1.4. Film Dressings
10.2.1.5. Alginate Dressings
10.2.1.6. Hydrogel Dressings
10.2.1.7. Other Dressings
10.2.2. Wound Care Devices
10.2.2.1. Negative Pressure Wound Therapy (NPWT)
10.2.2.2. Ultrasound Therapy
10.2.2.3. Others (HBOT & electromagnetic)
10.2.3. Active Therapies
10.2.3.1. Skin Grafts & Substitutes
10.2.3.2. Growth Factors
10.2.3.3. Others (hemostatic agents, sealants (collagen and fibrin sealants))
10.2.4. Others
10.2.4.1. Pressure Relief Devices
10.2.4.2. Traditional Wound Care Products
10.2.4.3. Others
10.3. Market Value Forecast, by Type of Wound, 2017-2027
10.3.1. Stage 1
10.3.2. Stage 2
10.3.3. Stage 3
10.3.4. Stage 4
10.4. Market Value Forecast, by End User, 2017-2027
10.4.1. Hospital Inpatient Settings
10.4.2. Hospital Outpatient Settings
10.4.3. Community Health Centers
10.4.4. Home Healthcare
10.5. Market Value Forecast, by Country, 2017-2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment
10.6.2. By Wound
10.6.3. By End User
10.6.4. By Country
11. Europe Pressure Ulcers Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment, 2017-2027
11.2.1. Wound Care Dressing
11.2.1.1. Antimicrobial Dressings
11.2.1.2. Foam Dressings
11.2.1.3. Hydrocolloid Dressings
11.2.1.4. Film Dressings
11.2.1.5. Alginate Dressings
11.2.1.6. Hydrogel Dressings
11.2.1.7. Other Dressings
11.2.2. Wound Care Devices
11.2.2.1. Negative Pressure Wound Therapy (NPWT)
11.2.2.2. Ultrasound Therapy
11.2.2.3. Others (HBOT & electromagnetic)
11.2.3. Active Therapies
11.2.3.1. Skin Grafts & Substitutes
11.2.3.2. Growth Factors
11.2.3.3. Others (hemostatic agents, sealants (collagen and fibrin sealants))
11.2.4. Others
11.2.4.1. Pressure Relief Devices
11.2.4.2. Traditional Wound Care Products
11.2.4.3. Others
11.3. Market Value Forecast, by Type of Wound, 2017-2027
11.3.1. Stage 1
11.3.2. Stage 2
11.3.3. Stage 3
11.3.4. Stage 4
11.4. Market Value Forecast, by End User, 2017-2027
11.4.1. Hospital Inpatient Settings
11.4.2. Hospital Outpatient Settings
11.4.3. Community Health Centers
11.4.4. Home Healthcare
11.5. Market Value Forecast, by Country/Sub-region, 2017-2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Treatment
11.6.2. By Wound
11.6.3. By End User
11.6.4. By Country/Sub-region
12. Asia Pacific Pressure Ulcers Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment, 2017-2027
12.2.1. Wound Care Dressing
12.2.1.1. Antimicrobial Dressings
12.2.1.2. Foam Dressings
12.2.1.3. Hydrocolloid Dressings
12.2.1.4. Film Dressings
12.2.1.5. Alginate Dressings
12.2.1.6. Hydrogel Dressings
12.2.1.7. Other Dressings
12.2.2. Wound Care Devices
12.2.2.1. Negative Pressure Wound Therapy (NPWT)
12.2.2.2. Ultrasound Therapy
12.2.2.3. Others (HBOT & electromagnetic)
12.2.3. Active Therapies
12.2.3.1. Skin Grafts & Substitutes
12.2.3.2. Growth Factors
12.2.3.3. Others (hemostatic agents, sealants (collagen and fibrin sealants))
12.2.4. Others
12.2.4.1. Pressure Relief Devices
12.2.4.2. Traditional Wound Care Products
12.2.4.3. Others
12.3. Market Value Forecast, by Type of Wound, 2017-2027
12.3.1. Stage 1
12.3.2. Stage 2
12.3.3. Stage 3
12.3.4. Stage 4
12.4. Market Value Forecast, by End User, 2017-2027
12.4.1. Hospital Inpatient Settings
12.4.2. Hospital Outpatient Settings
12.4.3. Community Health Centers
12.4.4. Home Healthcare
12.5. Market Value Forecast, by Country/Sub-region, 2017-2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Treatment
12.6.2. By Wound
12.6.3. By End User
12.6.4. By Country/Sub-region
13. Latin America Pressure Ulcers Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment, 2017-2027
13.2.1. Wound Care Dressing
13.2.1.1. Antimicrobial Dressings
13.2.1.2. Foam Dressings
13.2.1.3. Hydrocolloid Dressings
13.2.1.4. Film Dressings
13.2.1.5. Alginate Dressings
13.2.1.6. Hydrogel Dressings
13.2.1.7. Other Dressings
13.2.2. Wound Care Devices
13.2.2.1. Negative Pressure Wound Therapy (NPWT)
13.2.2.2. Ultrasound Therapy
13.2.2.3. Others (HBOT & electromagnetic)
13.2.3. Active Therapies
13.2.3.1. Skin Grafts & Substitutes
13.2.3.2. Growth Factors
13.2.3.3. Others (hemostatic agents, sealants (collagen and fibrin sealants))
13.2.4. Others
13.2.4.1. Pressure Relief Devices
13.2.4.2. Traditional Wound Care Products
13.2.4.3. Others
13.3. Market Value Forecast, by Type of Wound, 2017-2027
13.3.1. Stage 1
13.3.2. Stage 2
13.3.3. Stage 3
13.3.4. Stage 4
13.4. Market Value Forecast, by End User, 2017-2027
13.4.1. Hospital Inpatient Settings
13.4.2. Hospital Outpatient Settings
13.4.3. Community Health Centers
13.4.4. Home Healthcare
13.5. Market Value Forecast, by Country/Sub-region, 2017-2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Treatment
13.6.2. By Wound
13.6.3. By End User
13.6.4. By Country/Sub-region
14. Competitive Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. Smith & Nephew plc
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Company Financials
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. Integra LifeSciences
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Company Financials
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Hill-Rom Holdings, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Company Financials
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Mölnlycke Healthcare AB
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Company Financials
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Essity Aktiebolag
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Company Financials
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Cardinal Health
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Company Financials
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. 3M
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Company Financials
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. B. Braun Melsungen AG
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Company Financials
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. Acelity L.P., Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Company Financials
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis
14.3.10. Coloplast Group
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Company Financials
14.3.10.3. Growth Strategies
14.3.10.4. SWOT Analysis
14.3.11. ConvaTec Group PLC
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Company Financials
14.3.11.3. Growth Strategies
14.3.11.4. SWOT Analysis
*Note: Financial details for companies that do not report this information in public domain might not be captured